We are monitoring the impact of COVID-19 & Recession alarm on North America HIV Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

North America HIV Diagnostics Market Research Report - Segmented By Product, By Type, By End User & By Country(U.S, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 2053
Pages: 130

North America HIV Diagnostics Market Size & Growth (2022 to 2027):

As per the research report, the size of the North America HIV Diagnostics Market is valued at USD 850.20 million in 2022 and estimated to be growing at a CAGR of 9.0%, to reach 1308.14 million by 2027 during the forecast period 2022 to 2027.

The market is expected to develop due to the rising global prevalence of HIV/AIDS, the increasing number of blood transfusions and blood donations, the benefits provided by point-of-care tools and kits, and increased government initiatives. Throughout the forecast period, North America is expected to lead the global market. The presence of important companies, the high incidence of HIV/AIDS in the region, and developed healthcare infrastructure are key factors contributing to the market's large share. Additionally, reasonable government efforts and an increase in the number of research partnerships are likely to boost market expansion. Laboratory diagnosis of the human immunodeficiency virus (HIV) infection is critical for detecting and monitoring conditions.

Furthermore, various diagnostic methods rely on detecting HIV-specific antibodies, virus antigens, and nucleic acid. Again, as technology advances, HIV testing assays improve, resulting in increased sensitivity and specificity. The demand for HIV Diagnosis Market is being driven by an increase in blood transfusions and blood donations worldwide. Because most individuals are unaware that they have HIV, a single blood transfusion or blood donation infects most people, resulting in a higher demand for HIV diagnosis. Simple, quick assays with visual testing and easy-to-handle home sample collecting approaches utilized by health care personnel and customers at home have paved the way for this industry to grow. Increased use of HIV antigen, nucleic acid testing, and viral load testing, as well as rising research and development investment by crucial healthcare organizations, would provide lucrative and remunerative growth prospects for the market.

The lack of nucleic acid test mandates in developing nations is a crucial restriction to market expansion. During the forecast period 2020-2025, the high cost of HIV Diagnosis Test would act as a challenge for the HIV Diagnosis Market. Nucleic Acid Tests (NATs) are costly and are only used for HIV screening if a person has recently been exposed to a high risk of infection and has early indications of HIV infection.

This research report on the North America HIV diagnostics Market has been segmented and sub-segmented into the following categories:

By Product:

  • Consumables
  • Instruments
  • Software
  • Services                

By Type:

  • Antibody Tests
  • Viral Identification Tests
  • CD4 Testing
  • Viral Load testing
  • Early Infant Diagnostics              

By End User:

  • Diagnostic Laboratories
  • Hospitals
  • Blood Banks
  • Home Care Settings
  • Other End Users             

By Country:

  • U.S
  • Canada
  • Rest of North America

Geographically, the North America dominated the HIV Diagnosis Market, accounting for 39 percent of the market. A significant element driving its market expansion is the rise in health concerns and the need for improved diagnostic tests, rising health expenditure, and a better healthcare system.

Furthermore, the vast number of laboratories and easy access to technologically advanced instruments in that area increased incidence of HIV patients around the world, technological improvements, government initiatives, and rising blood donation leading to infections are all critical drivers driving the HIV Diagnosis Market during the forecast period 2020-2025. Furthermore, HIV antigens, nucleic acid testing, viral load testing, and CD4 testing to detect HIV infection are driving the market growth.

Due to a technologically advanced healthcare environment, favorable reimbursement regulations, and much higher healthcare research and development expenditure over the forecast period, the industry is expected to increase market demand due to technological advancements in quick and portable diagnostic testing. In the United States, favorable regulatory norms, a significant presence of significant biotech firms, and expanding healthcare spending will create a suitable environment for HIV testing products. In addition, the rising frequency of HIV infection and improved awareness about its detection and treatment are propelling the regional HIV diagnostics market forward.

KEY MARKET PARTICIPANTS

Companies playing a dominant role in the North America HIV diagnostics Market profiled in this report are Abbott Healthcare, Alere Inc., Abbvie Inc., Brsitol-Myers Squibb, Gilead Sciences, Merck & Co. Inc, Janssen Therapeutics, BD Biosciences, VIIV Healthcare, Partec, Sysmex, Beckman Coulter, Apogee Flow Systems, Mylan inc., PointCare Technologies Inc., Zyomyx Inc., Roche Diagnostics, Siemens Healthcare, Qiagen, and bioMerieux

1.Introduction                

                1.1 Market Definition  

                1.2 Study Deliverables

                1.3 Base Currency, Base Year and Forecast Periods        

                1.4 General Study Assumptions  

2. Research Methodology                         

                2.1 Introduction             

                2.2 Research Phases    

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design       

                2.4 Study Timeline        

3. Overview                     

                3.1 Executive Summary  

                3.2 Key Inferences       

                3.3 Epidemology            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                  

                4.1 Market Drivers        

                4.2 Market Restraints  

                4.3 Key Challenges       

                4.4 Current Opportunities in the Market            

5. Market Segmentation                            

                5.1 Product      

                                5.1.1 Introduction                                                           

                                5.1.2 Consumables                                                         

                                                5.1.2.1 Assays and Kits &Reagents                                           

                                                5.1.2.2 Other Consumables                                        

                                5.1.3 Instruments                                                           

                                5.1.4 Software & Services                                                            

                                5.1.5  Y-o-Y Growth Analysis, By Product                                                              

                                5.1.6  Market Attractiveness Analysis, By Product                                                            

                                5.1.7  Market Share Analysis, By Product                                                              

                5.2 Type            

                                5.2.1 Introduction                                                           

                                5.2.2 Antibody Tests                                                      

                                                5.2.2.1 HIV Screening Tests                                         

  5.2.2.1.1 Elisa                    

  5.2.2.1.2 Rapid Tests                      

  5.2.2.1.3 Home Access Dried Blood Spots                             

                                                5.2.2.2 HIV-1 Antibody Confirmatory Tests                                          

  5.2.2.2.1 Western Blot Tests                       

  5.2.2.2.2  Indirect Immunofluorescence Assays (IFA)                      

  5.2.2.2.3 Line Immunoassays                     

  5.2.2.2.4 Radio-Immunoprecipitation Assays                      

                                                5.2.2.3  HIV-2 & Group O Diagnostic Tests                                            

  5.2.2.3.1 Blood Antibody Tests                  

  5.2.2.3.2 DBS Tests                         

  5.2.2.3.3 Line ImmunoAssay (HIV2)                         

                                5.2.3 Viral Identification Tests                                                    

                                                5.2.3.1 p24 Antigen Test                                               

                                                5.2.3.2 Qualitative PCR Tests                                      

                                                5.2.3.3 Viral Culture                                        

                                5.2.4 CD4 Testing                                                             

                                5.2.5 Viral Load testing                                                  

                                5.2.6 Early Infant Diagnostics                                                      

                                5.2.7 Y-o-Y Growth Analysis, By Type                                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                                   

                                5.2.9 Market Share Analysis, By Type                                                     

                5.3 End User    

                                5.3.1 Introduction                                                           

                                5.3.2 Diagnostic Laboratories                                                     

                                5.3.3 Hospitals                                                  

                                5.3.4 Blood Banks                                                            

                                5.3.5 Home Care Settings                                                            

                                5.3.6 Other End Users                                                   

                                5.3.7 Y-o-Y Growth Analysis, By End User                                                             

                                5.3.8  Market Attractiveness Analysis, By End User                                                          

                                5.3.9  Market Share Analysis, By End User                                                            

6. Geographical Analysis                            

                6.1 Introduction             

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Product                                           

                                                6.1.3.3 By Type                                 

                                                6.1.3.4 By End User                                        

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Product                                           

                                                6.1.4.3 By Type                                 

                                                6.1.4.4 By End User                                        

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Product                                           

                                                6.1.5.3 By Type                                 

                                                6.1.5.4 By End User                                        

                6.2 United States          

                6.3 Canada       

7.Strategic Analysis                      

                7.1 PESTLE analysis       

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis            

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                                     

8.Market Leaders' Analysis                       

                8.1 Siemens Healthineers (A Division of Siemens AG)   

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Roche Diagnostics (Division of Hoffman La Roche Ltd.)          

                8.3 Abbott Laboratories             

                8.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)    

                8.5 Thermo-Fisher Scientific Inc.             

 8.6 Merck KGaA                                               

                8.7 Becton, Dickinson & Company                                           

                8.8 Hologic Inc.                                 

                8.9 Alere Inc.                                     

                8.10 Bio-Rad Laboratories                                            

9. Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                             

 

  1. North America HIV Diagnostics Market By Product, From 2022 - 2027 ( USD Million )
  2. North America Consumables Market By Region, From 2022 - 2027 ( USD Million )
  3. North America Instruments Market By Region, From 2022 - 2027 ( USD Million )
  4. North America Software & Services Market By Region, From 2022 - 2027 ( USD Million )
  5. North America HIV Diagnostics Market By Type, From 2022 - 2027 ( USD Million )
  6. North America Antibody Tests Market By Region, From 2022 - 2027 ( USD Million )
  7. North America Viral Identification tests Market By Region, From 2022 - 2027 ( USD Million )
  8. North America CD4 Testing Market By Region, From 2022 - 2027 ( USD Million )
  9. North America Viral Load Testing Market By Region, From 2022 - 2027 ( USD Million )
  10. North America Early Infant Diagnostics Market By Region, From 2022 - 2027 ( USD Million )
  11. North America HIV Diagnostics Market By End-User, From 2022 - 2027 ( USD Million )
  12. North America Diagnostic Labortaries Market By Region, From 2022 - 2027 ( USD Million )
  13. North America Hospitals Market By Region, From 2022 - 2027 ( USD Million )
  14. North America Blood Banks Market By Region, From 2022 - 2027 ( USD Million )
  15. North America Home Care Settings Market By Region, From 2022 - 2027 ( USD Million )
  16. North America Other End Users Market By Region, From 2022 - 2027 ( USD Million )
  17. United States HIV Diagnostics Market By Product, From 2022 - 2027 ( USD Million )
  18. United States HIV Diagnostics Market By Type, From 2022 - 2027 ( USD Million )
  19. United States HIV Diagnostics Market By End-User, From 2022 - 2027 ( USD Million )
  20. Canada HIV Diagnostics Market By Product, From 2022 - 2027 ( USD Million )
  21. Canada HIV Diagnostics Market By Type, From 2022 - 2027 ( USD Million )
  22. Canada HIV Diagnostics Market By End-User, From 2022 - 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample